MercadoLibre vs Amazon: Which E-Commerce Giant Stock Has More Upside? — Neutral

AMZN  MELI   Zacks Investment Research — November 19, 2025

MELI's margin pressure and regional volatility stack up against AMZN's steadier profit gains in the race for more upside.

image for news MercadoLibre vs Amazon: Which E-Commerce Giant Stock Has More Upside?

TSS Q3 Earnings & Revenues Fall Y/Y Even As 2026 Outlook Improves — Positive

TSSI   Zacks Investment Research — November 19, 2025

TSSI shares plunge after a weak Q3 earnings, but rising AI demand, stronger operations and upbeat guidance suggest growth may accelerate in 2026.

image for news TSS Q3 Earnings & Revenues Fall Y/Y Even As 2026 Outlook Improves

U.S. Outperformance in Sight? ETFs to Play Morgan Stanley's Forecast — Positive

MS   Zacks Investment Research — November 19, 2025

Morgan Stanley sees U.S. equities outpacing global markets into 2026, with AI-driven gains and small-cap strength supporting its upbeat S&P 500 outlook.

image for news U.S. Outperformance in Sight? ETFs to Play Morgan Stanley's Forecast

Dolby's Q4 Earnings & Revenues Surpass Estimates, Increase Y/Y — Positive

DLB   Zacks Investment Research — November 19, 2025

DLB posts a solid Q4 beat as product strength and growing Dolby Atmos and Vision adoption fuel a strong fiscal finish.

image for news Dolby's Q4 Earnings & Revenues Surpass Estimates, Increase Y/Y

RICHMOND, Va. , Nov. 19, 2025 /PRNewswire/ -- Indivior PLC (NASDAQ: INDV) today announced that it will participate in the Piper Sandler 37th Annual Healthcare Conference: Piper Sandler 37th Annual Healthcare Conference – New York City, NY Joe Ciaffoni, Chief Executive Officer, and Ryan Preblick, Chief Financial Officer, will host 1x1 / group meetings on Tuesday, December 2 nd.

image for news Indivior to Participate in the Piper Sandler 37th Annual Healthcare Conference

Louisville, CO, Nov. 19, 2025 (GLOBE NEWSWIRE) -- CEA Industries Inc. (Nasdaq: BNC) (“BNC” or the “Company”), which manages the world's largest corporate treasury of BNB, today announced the launch of its new Treasury Dashboard (“dashboard”), now live on CEAIndustries.com. The dashboard offers investors a consolidated and regularly updated view of certain of BNC's operating metrics, BNB holdings, treasury strategy, and capital markets activities.

image for news CEA Industries (BNC) Launches Comprehensive Treasury Dashboard and Provides Corporate Update

Conagra Brands: Income And Stability In A Turbulent Market — Positive

CAG   Seeking Alpha — November 19, 2025

Conagra Brands offers a defensive investment opportunity, trading at a multi-year low valuation and a forward P/E of 10. CAG's 8% dividend yield and stable, well-known brands support its appeal despite recent revenue and EPS declines. Recent earnings beat expectations, suggesting major headwinds may already be priced in, with a 5% stock uptick post-results.

image for news Conagra Brands: Income And Stability In A Turbulent Market

Oklo ($OKLO) | Pony.ai ($PONY) | Archer Aviation ($ACHR) | NANO Nuclear Energy ($NNE) — Positive

ACHR  NNE  OKLO  PONY   Green Stock News — November 19, 2025

Welcome to the Green Stock News brief for Wednesday November 19th. Here are today's top headlines: Oklo (NYSE: OKLO) and Siemens Energy signed a binding contract for Siemens to design and deliver the power conversion system for Oklo's first Aurora advanced fission reactor.

image for news Oklo ($OKLO) | Pony.ai ($PONY) | Archer Aviation ($ACHR) | NANO Nuclear Energy ($NNE)

Toyota Motor: Confirmed As A Durable Long-Term Defensive Buy After Q2 Results — Neutral

TM   Seeking Alpha — November 19, 2025

Toyota is transitioning from a traditional automaker into a software and services platform built on multiple strong brands. Its hybrid-focused approach protects margins and avoids risky overspending on BEVs. A more balanced global footprint and an expanding financial services arm reduce earnings volatility.

image for news Toyota Motor: Confirmed As A Durable Long-Term Defensive Buy After Q2 Results

Futures rise as Nvidia's high-stakes earnings test drives sentiment across tech stocks, US indices, and the broader stock market today.

image for news S&P500 and Nasdaq 100: Nvidia's 7% Implied Move Raises Stakes for US Stocks Today

DANIA BEACH, Fla.--(BUSINESS WIRE)--IntelePeer, an end-to-end conversational and agentic AI platform provider, today announced it has integrated advanced capabilities of Microsoft Azure Cosmos DB into its conversational and agentic AI platform, giving multi-location healthcare organizations and medical practices enterprise-grade performance and scalability for delivering superior patient experiences. The result of a collaborative effort by engineering teams at IntelePeer and Microsoft, the inte.

image for news IntelePeer Supercharges AI Platform with Microsoft Azure Cosmos DB for Enterprise-Grade Performance

Reddit proved business resilience supported by strong execution capability. Advertising revenue and ARPU are growing rapidly, with fast EBITDA margin improving toward industry-leading levels. Valuation is attractive, with a projected 30% revenue CAGR and strong capital returns justifying a premium, and a target price of $255 is set.

image for news Reddit: Business Resilience Undervalued, Healthy Consolidation Creates A Buying Opportunity

Can CleanSpark's Data Center Push Unlock New AI Revenue Streams? — Positive

CLSK   Zacks Investment Research — November 19, 2025

CLSK pivots from pure Bitcoin mining to build AI-ready data centers, aiming to unlock long-term growth through diversified digital infrastructure.

image for news Can CleanSpark's Data Center Push Unlock New AI Revenue Streams?

Lumen and Meter Launch AI-Driven WAN-to-LAN Solution for Enterprises — Positive

LUMN   Zacks Investment Research — November 19, 2025

LUMN's collaboration with Meter debuts a unified WAN-to-LAN solution built to simplify AI-ready enterprise connectivity and operations.

image for news Lumen and Meter Launch AI-Driven WAN-to-LAN Solution for Enterprises

Is Percipio the Key to Reshaping Skillsoft's Market Positioning? — Positive

SKIL   Zacks Investment Research — November 19, 2025

SKIL's Percipio drives soaring AI learning adoption and major workforce wins, strengthening its position in the evolving upskilling market.

image for news Is Percipio the Key to Reshaping Skillsoft's Market Positioning?

Gladstone Capital: The BDC Is Back On The Growth Track, It's A Buy — Positive

GLAD   Seeking Alpha — November 19, 2025

Gladstone Capital has been one of my equity-focused BDC picks, which as opposed to FDUS and TRIN has delivered unpleasant returns. Recently, GLAD announced a dividend cut, which also came as a surprise to me. Yet, the Q4 2025 data points, in my view, indicate a clear turning point.

image for news Gladstone Capital: The BDC Is Back On The Growth Track, It's A Buy

AUSTIN, Texas, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) today announced that its Board of Directors has initiated a review of strategic alternatives in order to explore ways to maximize shareholder value. The review will include a range of potential actions, including raising equity capital, reverse mergers, combination transactions, and the sale of all or part of the Company's business, and other possible strategic or financial transactions.

image for news Astrotech Announces Review of Strategic Alternatives to Maximize Shareholder Value

MIAMI, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that its submission entitled “Reduced brain neuroinflammation after laromestrocel treatment in mild AD: results from the CLEAR MIND study” has been selected for a poster presentation at the 18th Clinical Trials on Alzheimer's Disease Conference (CTAD 2025) to be held December 1-4, 2025 in San Diego, CA. “We are excited to have been selected to present important laromestrocel data at this leading forum for Alzheimer's research and clinical investigation,” said Joshua …

image for news Longeveron Laromestrocel Data in Alzheimer's Disease Selected for Poster Presentation at the Clinical Trials on Alzheimer's Disease Conference (CTAD 2025)

SAN DIEGO , Nov. 19, 2025 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced its Managed Access Program (MAP) for investigational therapy delpacibart zotadirsen (del-zota) for eligible people with Duchenne muscular dystrophy mutations amenable to exon 44 skipping (DMD44) in the United States. "We recognize the considerable needs facing the DMD44 community given there are no approved exon skipping therapies for this disease as well as the potential of del-zota based on the unprecedented data shown in our clinical studies," said Sarah …

image for news Avidity Biosciences Announces U.S. Managed Access Program (MAP) for Investigational Therapy del-zota in DMD44

Nvidia stock price has pulled back in the past two weeks, moving from the year-to-date high of $212 to $180. This retreat will either accelerate or reverse once the company publishes its financial results later today.

image for news Nvidia stock price forecast: NVDA is extremely cheap ahead of earnings